Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Palo Alto Networks

    Protecting Pharma from cyber attacks and systems misuse helping to ensure IP Protection and availability in manufacturing environments

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    Genetic Digital

    We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

    View Profile

    Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

    Nmblr

    From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

    View Profile

    IT solutions

    Company Details

    Palo Alto Networks
    4401 Great America Parkway, Santa Clara, CA, 95054, USA
    Contact Palo Alto Networks
    Website

     Latest Content from PMHub 

    ASCO 2015: What you missed in Chicago

    White Papers and Resources | June 15, 2015 | Blue Latitude Health

    Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations...

    Meet expert speakers: The right e-detailing content for rich data

    White Papers and Resources | June 1, 2015 | Anthill Agency

    We are excited to reveal the names of the expert speakers at Anthill's next webinar "The right e-detailing content for rich data" on the 3rd June 2015, 3 PM GMT+2.

    How do you solve a problem like non-adherence? Part 2

    White Papers and Resources | May 29, 2015 | Blue Latitude Health

    Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment...

    Webinar: The right e-detailing content for rich data

    White Papers and Resources | May 26, 2015 | Anthill Agency

    Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too.

    How do you solve a problem like non-adherence? Part 1

    White Papers and Resources | May 21, 2015 | Blue Latitude Health

    Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...

    How to design patient services with social media within the ABPI code guidelines

    White Papers and Resources | May 21, 2015 | Blue Latitude Health

    In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.

    Infographic: PsO market snapshot

    White Papers and Resources | May 19, 2015 | Inizio

    An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...

    Infographic: Prostate Cancer Market Snapshot

    White Papers and Resources | May 19, 2015 | Inizio

    An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...

    Infographic: LATAM

    White Papers and Resources | May 19, 2015 | Inizio

    Latin AmericaThe LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With...

    Infographic: RA market snapshot

    White Papers and Resources | May 19, 2015 | Inizio

    An overview of the RA biologic patientOur RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses...